• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

升高预示着结直肠癌患者预后不良。

Increased Predicts Poor Prognosis in Patients With Colorectal Carcinoma.

作者信息

Zhang Guoshun, Shang Hua, Liu Bin, Wu Guikai, Wu Diyang, Wang Liuqing, Li Shengnan, Wang Zhiyuan, Wang Suying, Yuan Juxiang

机构信息

School of Public Health, North China University of Science and Technology, Tangshan, China.

Department of Gastroenterology, Affiliated Hospital of North China University of Technology, Tangshan, China.

出版信息

Front Genet. 2022 Jun 16;13:661348. doi: 10.3389/fgene.2022.661348. eCollection 2022.

DOI:10.3389/fgene.2022.661348
PMID:35783262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9243465/
Abstract

Colorectal cancer is one of the most common malignant tumors in the digestive system. Traditional diagnosis and treatment methods have not significantly improved the overall survival of patients. In this study, we explored the value of as a biomarker in predicting the prognosis of colorectal cancer patients. We used the TCGA database to reveal the relationship between mRNA level and prognosis, methylation, and immune invasion in colorectal cancer. The results showed that the expression of was increased in colorectal cancer. The overall survival of patients with high expression of was significantly lower than patients with low expression of . Cox regression analysis showed that high expression of was an independent risk factor for poor prognosis in colorectal cancer patients. In addition, we used three datasets to perform a meta-analysis, which further confirmed the reliability of the results. Furthermore, we revealed that could significantly inhibit the proliferation of colorectal cancer cells by inhibiting the autophagy process and was associated with several immune cells, especially CD8 + T cells. Finally, four small molecule drugs with potential inhibition of expression were found by CMap analysis. This study demonstrates for the first time that is a potential pathogenic factor, which may play a significant role in colorectal cancer.

摘要

结直肠癌是消化系统最常见的恶性肿瘤之一。传统的诊断和治疗方法并未显著提高患者的总体生存率。在本研究中,我们探讨了[未提及具体指标]作为生物标志物在预测结直肠癌患者预后方面的价值。我们使用TCGA数据库揭示[未提及具体指标]mRNA水平与结直肠癌预后、甲基化及免疫浸润之间的关系。结果显示,[未提及具体指标]在结直肠癌中表达升高。[未提及具体指标]高表达患者的总体生存率显著低于低表达患者。Cox回归分析表明,[未提及具体指标]高表达是结直肠癌患者预后不良的独立危险因素。此外,我们使用三个数据集进行荟萃分析,进一步证实了结果的可靠性。此外,我们发现[未提及具体指标]可通过抑制自噬过程显著抑制结直肠癌细胞的增殖,并与多种免疫细胞相关,尤其是CD8 + T细胞。最后,通过CMap分析发现了四种具有潜在抑制[未提及具体指标]表达作用的小分子药物。本研究首次证明[未提及具体指标]是一种潜在的致病因素,可能在结直肠癌中发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e00e/9243465/3c91ae15c3aa/fgene-13-661348-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e00e/9243465/eb0e29a1be37/fgene-13-661348-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e00e/9243465/723f2e112844/fgene-13-661348-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e00e/9243465/571020d3550f/fgene-13-661348-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e00e/9243465/600717d7c8f8/fgene-13-661348-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e00e/9243465/dbb086110499/fgene-13-661348-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e00e/9243465/0facd412a655/fgene-13-661348-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e00e/9243465/3c91ae15c3aa/fgene-13-661348-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e00e/9243465/eb0e29a1be37/fgene-13-661348-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e00e/9243465/723f2e112844/fgene-13-661348-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e00e/9243465/571020d3550f/fgene-13-661348-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e00e/9243465/600717d7c8f8/fgene-13-661348-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e00e/9243465/dbb086110499/fgene-13-661348-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e00e/9243465/0facd412a655/fgene-13-661348-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e00e/9243465/3c91ae15c3aa/fgene-13-661348-g007.jpg

相似文献

1
Increased Predicts Poor Prognosis in Patients With Colorectal Carcinoma.升高预示着结直肠癌患者预后不良。
Front Genet. 2022 Jun 16;13:661348. doi: 10.3389/fgene.2022.661348. eCollection 2022.
2
Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.鉴定 ANXA1 作为结直肠癌的一个潜在预后生物标志物,并与免疫浸润相关。
Autoimmunity. 2021 Mar;54(2):76-87. doi: 10.1080/08916934.2021.1887148. Epub 2021 Feb 18.
3
SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.SEMA6B高表达预示结直肠癌预后不良并与肿瘤免疫抑制微环境相关。
Front Mol Biosci. 2021 Dec 6;8:687319. doi: 10.3389/fmolb.2021.687319. eCollection 2021.
4
Increased expression of NOP14 is associated with improved prognosis due to immune regulation in colorectal cancer.NOP14 的表达增加与结直肠癌的免疫调节有关,可改善预后。
BMC Gastroenterol. 2022 Apr 26;22(1):207. doi: 10.1186/s12876-022-02286-x.
5
[Characteristics of CD8+ T cell infiltration in colorectal cancer and their correlation with prognosis].[结直肠癌中CD8+T细胞浸润特征及其与预后的相关性]
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Dec 25;24(12):1086-1092. doi: 10.3760/cma.j.cn441530-20210402-00144.
6
Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma.PRDM5 低表达预示着食管鳞癌预后不良。
BMC Cancer. 2022 Jul 7;22(1):745. doi: 10.1186/s12885-022-09787-8.
7
Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer.丝裂原活化蛋白激酶14是一种预后生物标志物,与结直肠癌的临床病理特征和免疫浸润相关。
Front Cell Dev Biol. 2022 Jan 24;10:817800. doi: 10.3389/fcell.2022.817800. eCollection 2022.
8
High PHD Finger Protein 19 (PHF19) expression predicts poor prognosis in colorectal cancer: a retrospective study.高PHD指蛋白19(PHF19)表达预示结直肠癌预后不良:一项回顾性研究。
PeerJ. 2021 Jun 1;9:e11551. doi: 10.7717/peerj.11551. eCollection 2021.
9
Bioinformatics Analysis Combined With Experiments Predicts PUDP as a Potential Prognostic Biomarker for Hepatocellular Carcinoma Through Its Interaction With Tumor Microenvironment.生物信息学分析结合实验通过与肿瘤微环境的相互作用预测PUDP作为肝细胞癌的潜在预后生物标志物。
Front Oncol. 2022 Mar 8;12:830174. doi: 10.3389/fonc.2022.830174. eCollection 2022.
10
CRYAB predicts clinical prognosis and is associated with immunocyte infiltration in colorectal cancer.CRYAB可预测结直肠癌的临床预后并与免疫细胞浸润相关。
PeerJ. 2021 Dec 10;9:e12578. doi: 10.7717/peerj.12578. eCollection 2021.

引用本文的文献

1
Modulation of Endoplasmic Reticulum Stress in Experimental Anti-Cancer Therapy.实验性抗癌治疗中内质网应激的调节
Int J Mol Sci. 2025 Jul 3;26(13):6407. doi: 10.3390/ijms26136407.
2
Lactobacillus gasseri ATCC33323 affects the intestinal mucosal barrier to ameliorate DSS-induced colitis through the NR1I3-mediated regulation of E-cadherin.发酵乳杆菌 ATCC33323 通过 NR1I3 介导的 E-钙黏蛋白调节改善 DSS 诱导的结肠炎对肠黏膜屏障的影响。
PLoS Pathog. 2024 Sep 9;20(9):e1012541. doi: 10.1371/journal.ppat.1012541. eCollection 2024 Sep.
3
In vitro culture alters cell lineage composition and cellular metabolism of bovine blastocyst†.

本文引用的文献

1
Transcriptomic-Based Identification of the Immuno-Oncogenic Signature of Cholangiocarcinoma for HLC-018 Multi-Target Therapy Exploration.基于转录组学的胆管癌免疫原性特征鉴定及其在 HLC-018 多靶点治疗探索中的应用。
Cells. 2021 Oct 25;10(11):2873. doi: 10.3390/cells10112873.
2
Altered SERCA Expression in Breast Cancer.乳腺癌中 SERCA 的改变。
Medicina (Kaunas). 2021 Oct 8;57(10):1074. doi: 10.3390/medicina57101074.
3
Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients.XRCC2 过表达是胶质母细胞瘤患者预后不良的独立危险因素。
体外培养改变牛囊胚的细胞谱系组成和细胞代谢。
Biol Reprod. 2024 Jul 12;111(1):11-27. doi: 10.1093/biolre/ioae031.
4
Construction of a prognostic risk model for Stomach adenocarcinoma based on endoplasmic reticulum stress genes.基于内质网应激基因构建胃腺癌预后风险模型。
Wien Klin Wochenschr. 2024 Jun;136(11-12):319-330. doi: 10.1007/s00508-023-02306-0. Epub 2023 Nov 22.
5
Exploring tumor-normal cross-talk with TranNet: Role of the environment in tumor progression.探讨 TranNet 中的肿瘤-正常细胞串扰:环境在肿瘤进展中的作用。
PLoS Comput Biol. 2023 Sep 18;19(9):e1011472. doi: 10.1371/journal.pcbi.1011472. eCollection 2023 Sep.
6
Exploring tumor-normal cross-talk with TranNet: role of the environment in tumor progression.利用TranNet探索肿瘤与正常组织的相互作用:环境在肿瘤进展中的作用
bioRxiv. 2023 Feb 24:2023.02.24.529899. doi: 10.1101/2023.02.24.529899.
Mol Med. 2021 May 29;27(1):52. doi: 10.1186/s10020-021-00316-0.
4
EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles.针对癌症治疗的 EGFR 靶向:药物和纳米颗粒的药理学和免疫偶联物。
Int J Pharm. 2021 Jan 5;592:120082. doi: 10.1016/j.ijpharm.2020.120082. Epub 2020 Nov 12.
5
The science and medicine of human immunology.人类免疫学的科学与医学。
Science. 2020 Sep 25;369(6511). doi: 10.1126/science.aay4014.
6
Prognostic significance of ARL9 and its methylation in low-grade glioma.ARL9 及其甲基化在低级别胶质瘤中的预后意义。
Genomics. 2020 Nov;112(6):4808-4816. doi: 10.1016/j.ygeno.2020.08.035. Epub 2020 Sep 1.
7
Identification of hub genes and small-molecule compounds in medulloblastoma by integrated bioinformatic analyses.通过综合生物信息学分析鉴定髓母细胞瘤中的枢纽基因和小分子化合物
PeerJ. 2020 Apr 14;8:e8670. doi: 10.7717/peerj.8670. eCollection 2020.
8
Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance.靶向泛素-蛋白酶体通路克服抗癌药物耐药性。
Drug Resist Updat. 2020 Jan;48:100663. doi: 10.1016/j.drup.2019.100663. Epub 2019 Nov 11.
9
Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy.肿瘤微环境中的免疫细胞:在癌症免疫治疗中的生物学功能和作用。
Cancer Lett. 2020 Feb 1;470:126-133. doi: 10.1016/j.canlet.2019.11.009. Epub 2019 Nov 12.
10
Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer.肿瘤浸润免疫细胞可作为结直肠癌预后的标志物。
Front Immunol. 2019 Oct 17;10:2368. doi: 10.3389/fimmu.2019.02368. eCollection 2019.